(Q40735449)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Oriana Nanni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Emanuela Scarpi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A Volpi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F De Paola

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A M Granato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Bajorko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Becciolini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Riccobon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Amadori

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

181-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110052%20AND%20SRC:MED&resulttype=core&format=json

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Caspases: intracellular signaling by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Amplification of a novel v-erbB-related gene in a human mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Implications of the p53 tumor-suppressor gene in clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Cell kinetics as a prognostic marker in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Prognostic role of p27Kip1 and apoptosis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Tritiated Thymidine Labeling Index and Response in Human Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Angiogenesis and breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer. The SICCAB Group for Quality Control of Cell Kinetic Determination

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Cell proliferation and its relationship to clinical features and relapse in breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

The long-term prognostic significance of the thymidine labelling index in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Prediction of early course of breast carcinoma by thymidine labeling

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

The DNA labelling index: a prognostic factor in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Cell kinetics as a prognostic indicator in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006464426977

7 January 2021